ASTHMA ALLERGY AND INFLAMMATION RESEARCH TRUST LIMITED
Financial health, per its FY2025 accounts
The accounts state that the charity achieved an overall surplus of £258,012 for the year ended 31 August 2025, driven primarily by legacies totaling £305,151. Unrestricted funds increased to £623,712, which significantly exceeds the charity's stated reserves policy target of retaining at least £100,000. The trustees confirm that resources are adequate to continue operations with no material uncertainties identified.
What the accounts disclose
“the charity's policy is to retain at least £100,000 of Uncommitted Funds, this level being reviewed annually.”
“During the year, £13,976 (2024: £12,778) was payable to a company in which the trustee, Mr L A Dunn, has an interest, for administrative services provided to the charity by two of that company's employees. No benefit accrues to Mr Dunn, or the company in which he has an interest, the additional costs to the company (including salary and Employers' National Insurance) being matched by payments made by the charity. At 31 August 2025, £Nil (2024: £Nil) was unpaid and £Nil (2024: £1,660) was accrued in respect of the services provided during the year.” — page 28
“During the year, no grants were awarded for research projects in which trustees had an interest (2024: One grant totalling £10,000).” — page 28
“During the year, £13,976 (2024: £12,778) was payable to a company in which the trustee, Mr L A Dunn, has an interest, for administrative services provided to the charity by two of that company's employees. No benefit accrues to Mr Dunn, or the company in which he has an interest, the additional costs to the company (including salary and Employers' National Insurance) being matched by payments made by the charity. At 31 August 2025, £Nil (2024: £Nil) was unpaid and £Nil (2024: £1,660) was accrued in respect of the services provided during the year.” — page 28
“During the year, no grants were awarded for research projects in which trustees had an interest (2024: One grant totalling £10,000).” — page 28
Corporate structure
- Registered company of the charity Companies House 06767479
Trustees
- PROFESSOR DONNA E DAVIESchair
- Dr Cornelia Blume Dr
- Dr JOANNE SLATER-JEFFERIES
- Laurence Dunn
- Mark Jones Professor
- PROFESSOR STEPHEN TOWNLEY HOLGATE MD DSC
- Professor Emily Swindle Dr
- Professor Graham Roberts
- Professor JANE LUCAS
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/08/2025 | £320k | £90k |
| 31/08/2024 | £48k | £97k |
| 31/08/2023 | £47k | £80k |
| 31/08/2022 | £8k | £68k |
| 31/08/2021 | £36k | £141k |
Common questions
Is ASTHMA ALLERGY AND INFLAMMATION RESEARCH TRUST LIMITED financially healthy?
The accounts state that the charity achieved an overall surplus of £258,012 for the year ended 31 August 2025, driven primarily by legacies totaling £305,151. Unrestricted funds increased to £623,712, which significantly exceeds the charity's stated reserves policy target of retaining at least £100,000. The trustees confirm that resources are adequate to continue operations with no material uncertainties identified. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| JUVENILE DIABETES RESEARCH FOUNDATION LIMITED | 1 | £38k |
| CANTIACORUM FOUNDATION | 1 | £1k |
| THE IAN ASKEW CHARITABLE TRUST | 1 | £1k |